Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04105114
Other study ID # 19.0434
Secondary ID 1R01NS102920-01A
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date September 30, 2019
Est. completion date December 31, 2027

Study information

Verified date February 2024
Source University of Louisville
Contact Andrea Willhite, MS
Phone 502-582-8675
Email andrea.willhite@louisville.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main goal of the project is to develop multiple noninvasive neuromodulatory strategies to facilitate full weight bearing stepping overground in people with paralysis. We will determine the effectiveness of combining noninvasive spinal cord stimulation and the administration of buspirone (a monoaminergic agonist) in facilitating locomotor activity in a gravity-neutral apparatus, during body weight supported stepping on a treadmill, when stepping overground in an assistive robotic exoskeleton, or during full weight bearing stepping overground in a rolling walker. Our objective is to identify the experimental variables that define the efficacy of these novel neuromodulatory techniques over a 5 year period in 15 participants with severe spinal cord injury who are at least one year post-injury.


Description:

Aim 1: Define the relative effectiveness of transcutaneous electrical stimulation at multiple stimulation spinal sites and oral Buspirone in facilitating nonweight-bearing (gravity neutral device, GND) and weight-bearing (treadmill) stepping in individuals with chronic motor complete paralysis. Aim 1.1: Define the relative effectiveness of transcutaneous electrical stimulation at multiple spinal sites to facilitate non-weight-bearing (GND) and weight-bearing (treadmill) stepping in spinal cord injury subjects. Aim 1.2: Define the relative effectiveness of transcutaneous electrical stimulation at multiple spinal sites plus oral Buspirone to facilitate nonweight-bearing (gravity neutral device, GND) and weight-bearing (treadmill) stepping in spinal cord injury subjects. Aim 2: Determine the relative effectiveness of Ekso-technology combined with transcutaneous electrical stimulation and/or oral Buspirone in lowering the robotic assistance and enhancing the ability to step self-assisted in a rolling walker during over-ground stepping in individuals with a chronic, severe (AIS A/B) spinal injury. Aim 3: Determine the relative effectiveness of Ekso-technology combined with transcutaneous electrical stimulation and/or oral Buspirone in lowering the robotic assistance and enhancing the ability to step self-assisted in a rolling walker during over-ground stepping in individuals with motor incomplete (AIS C) paralysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date December 31, 2027
Est. primary completion date August 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Ages 18-65 years old; 2. Stable medical condition; 3. More than 12 month's post injury; 4. Non-progressive spinal cord injury, AIS grade of A, B or C; 5. Neurological level of injury below T1 and above T8; 6. Not taking anti-spasticity medications; 7. Presence of active spinally evoked responses over the lumbo-sacral spinal cord using spinal stimulation; 8. Discontinuation of monoamine oxidase inhibitor (if applicable) for at least 2 weeks prior to initiation of treatment with buspirone. Exclusion Criteria: 1. Active pressure sores; 2. Unhealed bone fractures; 3. Untreated active urinary tract infections; 4. Peripheral neuropathies; 5. Seizure disorders; 6. Cardiopulmonary disease unrelated to spinal cord injury; 7. Anemia; 8. Painful musculoskeletal dysfunction; 9. Contractures in the lower extremities; 10. Lower extremity hardware implantation; 11. Lower extremity lower motor neuron injury; 12. Previous unhealed lower extremity musculoskeletal injuries or disorders, prior to or in conjunction with spinal cord injury; 13. Ventilator dependency; 14. Pregnancy or nursing; 15. Healing wounds/surgical sites along the spine, levels T9-L5; 16. Anti-spasticity implantable pumps; 17. Clinically significant depression, psychiatric disorders, or ongoing drug abuse; 18. Implantable suprapubic catheters; 19. Individuals who are unable to support themselves and/or have difficulty standing; 20. Individuals with abnormal blood panel results related to hepatic function. Up to 10 ml of venous blood will be obtained for the testing; 21. Individuals with increased Creatinine Clearance (Clcr) levels above the normal range; 22. Individuals who are taking drug(s) that interact(s) with Buspirone (BuSpar): Monoamine oxidase inhibitors (MAOIs) - Selegiline (Emsam), Isocarboxazid (Marplan), Phenelzine (Nardil), and Tranylcypromine (Parnate) /these medications must discontinue for at least 2 weeks prior to initiating treatment with Buspirone/; Selective serotonin reuptake inhibitors (SSRIs) - Nefazodone (Serzone) and Trazodone (Oleptro); the blood thinner - Warfarin (Coumadin); Unti-seizure drugs: Phenytoin (Dilantin) and Carbamazepine (Tegretol); Benzodiazepines - Diazepam (Valium) and Triazolam (Halcion); Muscle relaxant - Cyclobenzaprine (Flexeril); Anti-fungal drugs - Itraconazole (Sporanox, Onmel), Itraconazole (Sporanox), and Ketoconazole (Nizoral); Antibiotics - Erythromycin (E.E.S., E-Mycin, Erythrocin) and Rifampin (Rifadin, Rimactane); Steroids (Prednisone and others); Anti-HIV drug - Ritonavir (Norvir); Anti-hypertensive drugs - Diltiazem (Cardizem) and Verapamil (Calan, Verelan, Covera-HS); Anti-psychotic drug - Haloperidol (Haldol); 23. Uncontrolled autonomic dysreflexia; 24. Osteoporosis.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Buspirone
Oral Buspirone 7.5mg - 10mg daily during the treatment phase.
Device:
Non-invasive Spinal Cord Stimulation
A non-invasive transcutaneous electrical spinal cord stimulator, which can be used a multiple spinal locations.
Ekso Bionics Exoskeleton
This robotic exoskeleton is designed to assist people with neurological injuries for balance, standing, and stepping overground.
Gravity Neutral Device
This device is used to train and assess non-weight bearing stepping movements. When using the device, participants will be lying on their side with their legs suspended off the end of a table supported by small slings that are anchored securely to the apparatus.
Body Weight Supported Treadmill Training
Participants will be supported by a special harness while they are stepping on a treadmill. Trained technicians or therapists will be assist the trunk and legs during stepping as needed.
Rolling Walker
A standard rolling walker will be used for balance support and stability during stepping overground.

Locations

Country Name City State
United States Frazier Rehabilitation and Neuroscience Institute Louisville Kentucky

Sponsors (2)

Lead Sponsor Collaborator
University of Louisville National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Lower Extremity Electromyography, change over time Assessment of muscle activity, measured by electromyography, while the leg is suspended in a gravity neutral position. Before and after each study phase, 1 year per group.
Primary Lower Extremity Kinematics, change over time Assessment of low extremity 3D position, measured by motion analysis system, while the leg is suspended in a gravity neutral position. Before and after each study phase, 1 year per group.
Primary Treadmill Electromyography Assessment, change over time Muscle activity, measured by electromyography, will be recorded during weight supported stepping on a treadmill. Before and after each study phase, 1 year per group.
Primary Spinal Pathway Electrophysiology, change over time Evoked potentials in the lower extremities will recorded in response to nerve or spinal stimulation. Before and after each study phase, 1 year per group.
Primary Voluntary Lower Extremity Angles, change over time Assessments of knee, ankle, and toe movements will be performed by measuring angles produced during flexion and extension. The same units of measure will be used for each part of the leg. Before and after each study phase, 1 year per group.
Primary Voluntary Lower Extremity Forces, change over time Assessments of knee, ankle, and toe forces during movements will be performed by measuring forces produced during flexion and extension. The same units of measure will be used for each part of the leg. Before and after each study phase, 1 year per group.
Primary Body Temperature, change over time We will measure body temperature using standard methods to assess values at rest and during exercise. Before and after each study phase, 1 year per group.
Primary Blood Pressure, change over time We will measure blood pressure (systolic and diastolic) using standard methods to assess values at rest and during exercise. Before and after each study phase, 1 year per group.
Primary Heart Rate, change over time We will measure the heart rate using standard electrocardiography to assess values at rest and during exercise. Before and after each study phase, 1 year per group.
Primary Respiration Rate, change over time We will measure respiratory rate using standard methods to assess values at rest and during exercise. Before and after each study phase, 1 year per group.
Primary Dual-energy X-ray absorptiometry, change over time We will use dual-energy X-ray absorptiometry to measure bone and soft tissue density. Before and after each study phase, 1 year per group.
Primary Acoustic Gastro-Intestinal Surveillance, change over time We will use non-invasive sensors placed on the abdomen to detect signals related to the digestive state. Before and after each study phase, 1 year per group.
Primary Bladder capacity, change over time We will use a standard technique to measure bladder volume change during voiding. Before and after each study phase, 1 year per group.
Primary Urodynamics, change over time We will use a standard technique to measure the abdominal pressure change during voiding. Before and after each study phase, 1 year per group.
Primary Cognitive interference, change over time A cognitive assessment using Stroop test will be administered to assess cognitive function during stress. Before and after each study phase, 1 year per group.
Primary Assessment of verbal fluency, change over time Controlled Oral Word Association Test (COWAT) will be administered to assess verbal fluency that measures ability of spontaneous production of words. Before and after each study phase, 1 year per group.
Secondary International Standards of Neurological Classification of Spinal Cord Injury, change over time This standard clinical assessment assess the level and severity of a spinal cord injury.
The neurological level of injury is rated from A-E. "A" is a motor and sensory complete injury. "E" is completely normal at each spinal segment.
Sensory function is rated as 0-2, or Not Testable. Motor function is rated as 0-5 or Not Testable.
Before and after each study phase, 1 year per group.
Secondary Spinal Cord Injury Functional Ambulation Inventory, change over time This 3-part scale measures gait parameters, use of assistive devices, and distances traveled during walking. The gait parameters are scored on a 20-point scale, the assistive device use on a 14-point scale, and the walking distance on a 5-point scale. Before and after each study phase, 1 year per group.
Secondary Spinal Cord Independence Measure III, change over time This 3-part scale is scored out of 100 points possible. The first part (self-care) is scored out of 20. The second part (respiration and sphincter management) is scored out of 40. And the last part (mobility) is scored out of 40. Before and after each study phase, 1 year per group.
Secondary Walking Index for Spinal Cord Injury-II, change over time This is a 20-point scale used to assess the amount of physical assistance needed during walking. Before and after each study phase, 1 year per group.
Secondary Ashworth Scale, change over time This is a 6-part scale to measure and quantify the amount of muscle tone experienced when a joint is moved through a full range of motion. Before and after each study phase, 1 year per group.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06321172 - Muscle and Bone Changes After 6 Months of FES Cycling N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05484557 - Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Not yet recruiting NCT05506657 - Early Intervention to Promote Return to Work for People With Spinal Cord Injury N/A
Recruiting NCT03680872 - Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System N/A
Completed NCT04221373 - Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT03898700 - Coaching for Caregivers of Children With Spinal Cord Injury N/A
Recruiting NCT04883463 - Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury N/A
Active, not recruiting NCT04881565 - Losing Balance to Prevent Falls After Spinal Cord Injury (RBT+FES) N/A
Completed NCT04864262 - Photovoice for Spinal Cord Injury to Prevent Falls N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Active, not recruiting NCT04544761 - Resilience in Persons Following Spinal Cord Injury
Completed NCT03220451 - Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients N/A
Terminated NCT03170557 - Randomized Comparative Trial for Persistent Pain in Spinal Cord Injury: Acupuncture vs Aspecific Needle Skin Stimulation N/A
Recruiting NCT04811235 - Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial N/A
Recruiting NCT04736849 - Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury N/A
Active, not recruiting NCT05558254 - ROBERT® as an Intervention to Enhance Muscle Strength After Spinal Cord Injury N/A